AVE vs CYP

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

49LOW

CYP

CYNATA THR FPO [CYP]

49LOW

Score Breakdown

AVE CYP
Technical
69
60
Catalyst
54
50
Sentiment
50
50
Fundamental
54
35
Momentum
71
67
Risk Gate
35
42

Key Metrics

AVE Metric CYP
$33.1MMarket Cap$73.6M
7.9MAvg Volume (20d)184K
N/AShort InterestN/A
$0.01252-Week High$0.435
$0.00452-Week Low$0.140
+0.0%Daily Change+1.7%
$0.009Entry Price$0.305
-182.9%ROE-113.0%
N/AProfit MarginN/A

Active Signals

AVE Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-17%)
●Small-cap ($20-100M)

CYP Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.2x normal while price falls — heavy selling pressure
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.3 quarters)
●4C filed 2026-01-28
●Revenue declining (-10%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

Ask Scout AI to compare AVE and CYP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
AVE Full Analysis → CYP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).